These results suggest that MUC13-induced altered glucose metabolism involves the activation of important proteins, such as Glut-1 and HIF-1α, which may be contributing to MUC13-mediated adaptive cellular mechanisms in tumor microenvironment to maintain a glycolytic phenotype. This evidence concerns the gene SLC2A1 and neoplasm.